Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda R Grimes

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Chromosoma|September 1, 2005
Artificial and engineered chromosomes: developments and prospects for gene therapyBrenda R Grimes, Zoia Larin Monaco
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Alpha-satellite DNA and vector composition influence rates of human artificial chromosome formationBrenda R Grimes, Angela A Rhoades, Huntington F Willard
Transgenic Research|July 10, 2008
Identifying and genotyping transgene integration lociZhong Liang, Amy Marie Breman, Brenda R Grimes, et al.
Cytotherapy|January 22, 2011
Human umbilical cord blood plasma can replace fetal bovine serum for in vitro expansion of functional human endothelial colony-forming cellsLan Huang, Paul J Critser, Brenda R Grimes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 7, 2007
Input DNA ratio determines copy number of the 33 kb Factor IX gene on de novo human artificial chromosomesAmy M Breman, Camie M Steiner, Roger B Slee, et al.
Genome Biology|November 13, 2004
Assembly and characterization of heterochromatin and euchromatin on human artificial chromosomesBrenda R Grimes, Jennifer Babcock, M Katharine Rudd, et al.
Molecular Carcinogenesis|April 29, 2015
Widespread telomere instability in prostatic lesionsLiRen Tu, Nazmul Huda, Brenda R Grimes, et al.
Nucleic Acids Research|September 28, 2014
A portable BRCA1-HAC (human artificial chromosome) module for analysis of BRCA1 tumor suppressor functionArtem V Kononenko, Ruchi Bansal, Nicholas C O Lee, et al.
Future Oncology (London, England)|May 25, 2022
A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancerKristin M Sheffield, Jessica R Peachey, Michael Method, et al.
BMC Cancer|May 23, 2013
A new assay for measuring chromosome instability (CIN) and identification of drugs that elevate CIN in cancer cellsHee-Sheung Lee, Nicholas C O Lee, Brenda R Grimes, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Chromosoma|September 1, 2005
Artificial and engineered chromosomes: developments and prospects for gene therapyBrenda R Grimes, Zoia Larin Monaco
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Alpha-satellite DNA and vector composition influence rates of human artificial chromosome formationBrenda R Grimes, Angela A Rhoades, Huntington F Willard
Transgenic Research|July 10, 2008
Identifying and genotyping transgene integration lociZhong Liang, Amy Marie Breman, Brenda R Grimes, et al.
Cytotherapy|January 22, 2011
Human umbilical cord blood plasma can replace fetal bovine serum for in vitro expansion of functional human endothelial colony-forming cellsLan Huang, Paul J Critser, Brenda R Grimes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 7, 2007
Input DNA ratio determines copy number of the 33 kb Factor IX gene on de novo human artificial chromosomesAmy M Breman, Camie M Steiner, Roger B Slee, et al.
Genome Biology|November 13, 2004
Assembly and characterization of heterochromatin and euchromatin on human artificial chromosomesBrenda R Grimes, Jennifer Babcock, M Katharine Rudd, et al.
Molecular Carcinogenesis|April 29, 2015
Widespread telomere instability in prostatic lesionsLiRen Tu, Nazmul Huda, Brenda R Grimes, et al.
Nucleic Acids Research|September 28, 2014
A portable BRCA1-HAC (human artificial chromosome) module for analysis of BRCA1 tumor suppressor functionArtem V Kononenko, Ruchi Bansal, Nicholas C O Lee, et al.
Future Oncology (London, England)|May 25, 2022
A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancerKristin M Sheffield, Jessica R Peachey, Michael Method, et al.
BMC Cancer|May 23, 2013
A new assay for measuring chromosome instability (CIN) and identification of drugs that elevate CIN in cancer cellsHee-Sheung Lee, Nicholas C O Lee, Brenda R Grimes, et al.
Pageof 2